Sep 6, 2024, 18:00 by Kelly Corredor

ASAM's fall 2024 regulatory update

Sep 6, 2024, 17:54 by Kelly Corredor

ASAM comments on 2025 proposals from CMS.

Sep 6, 2024, 15:50 by Molly McGrath

The Legal Action Center has compiled resources about the Residential Recovery for Seniors Act (RRSA).

Sep 4, 2024, 10:43 by ASAM Weekly Editors

Virtual reality-based Mindfulness-Oriented Recovery Enhancement (MORE-VR)

Aug 28, 2024, 10:34 by ASAM Weekly Editors

The Lancet Psychiatry Commission on Youth Mental Health

Aug 21, 2024, 15:41 by ASAM Weekly Editors

Alcohol Consumption Patterns and Mortality Among Older Adults

Aug 14, 2024, 12:21 by ASAM Weekly Editors

Physicians not widely adopting evidence-based practices to help reduce addiction morbidity and mortality

Aug 12, 2024, 17:22 by Stuart Gitlow, MD, MPH, MBA, DFAPA, DFASAM

By now, addiction specialists understand the depth and impact of the drug overdose death crisis in the United States. We’ve read that, “Drug overdoses are one of the leading causes of injury death in adults and have risen over the past several decades… In 2022, 107,941 drug overdose deaths occurred.” Studies published in the past year alone highlight the toll overdose is taking on communities and families, with health disparities and inequities in care often exacerbating negative health outcomes for those most in need.

Aug 8, 2024, 08:47 by Molly McGrath

Aug 7, 2024, 13:39 by ASAM Weekly Editors

Rapid Initiation of Injectable Extended-Release Naltrexone for Opioid Use Disorder: A Time for Paradigm Shift in Treatment Protocols

Aug 5, 2024, 16:21 by Stuart Gitlow, MD, MPH, MBA, DFAPA, DFASAM

The opioid crisis remains a critical public health issue in the United States, contributing to over 80,000 opioid overdose deaths in 2023 alone.

Aug 5, 2024, 14:52 by Kelly Corredor

Jul 31, 2024, 12:53 by ASAM Weekly Editors

Guest Editorial: Does Rescheduling Cannabis Make Sense?

Jul 30, 2024, 17:50 by Kelly Corredor

CMS publishes important 2025 proposals for Addiction Medicine.

Jul 30, 2024, 13:54 by Stuart Gitlow, MD, MPH, MBA, DFAPA, DFASAM

On May 16, the Department of Justice (DOJ) proposed moving marijuana from Schedule I to Schedule III of the Controlled Substances Act. Between now and November’s election, there will be considerable discussion regarding rescheduling.

Jul 24, 2024, 13:26 by ASAM Weekly Editors

Guest Editorial: To Address the Fentanyl Crisis, Greater Access to Methadone Is Needed

Jul 22, 2024, 17:31 by Kelly Corredor

Jul 22, 2024, 15:20 by By Nora D. Volkow, MD

Over the past several years, the increasing prevalence of fentanyl in the drug supply has created an unprecedented overdose death rate and other devastating consequences.

Jul 22, 2024, 00:00 by ASAM Weekly Editors

Jul 19, 2024, 14:43 by Kelly Corredor

ASAM comments on marijuana rescheduling proposal.